{"id":"CHEMBL1004","canonicalSmiles":"CN(C)CCOC(C)(c1ccccc1)c1ccccn1","inchiKey":"HCFDWZZGGLSKEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXYLAMINE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Decapryn","Doxy-Sleep-Aid","Doxylamine","Unisom"],"crossReferences":{"DailyMed":["doxylamine%20succinate"],"PubChem":["90340822"],"Wikipedia":["Doxylamine"],"drugbank":["DB00366"],"chEBI":["51380"]},"childChemblIds":["CHEMBL1200392"],"count":1,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0000544","HP_0002017","EFO_0003785"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1948 and is indicated for allergy."}
{"id":"CHEMBL101253","canonicalSmiles":"Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1","inchiKey":"YCOYDOIWSSHVCK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VATALANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-86-5127","CGP-79787","K-222584","NVP-PTK787","PTK-787","PTK787","Ptk-787","Vatalanib","ZK-222584"],"crossReferences":{"PubChem":["103905548","104171421","144206361","170466113","50100112"],"Wikipedia":["Vatalanib"],"drugbank":["DB04879"],"chEBI":["90620"]},"childChemblIds":["CHEMBL75232","CHEMBL2142861"],"count":30,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000113721","ENSG00000157404","ENSG00000182578"],"count":7},"linkedDiseases":{"rows":["EFO_0003869","EFO_0001365","EFO_1001901","EFO_0000756","EFO_1000657","MONDO_0007254","MONDO_0002087","EFO_0002430","Orphanet_892","MONDO_0002158","EFO_0000588","EFO_0000339","MONDO_0002974","EFO_0000389","EFO_0004288","EFO_1000158","EFO_0000616","EFO_0002618","MONDO_0008170","EFO_0000403","EFO_0000222","MONDO_0008315","EFO_0003060","EFO_0000311","EFO_0009708","MONDO_0011962","MONDO_0002367","EFO_0001378","EFO_0000691","EFO_0000519"],"count":30},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 30 investigational indications."}
{"id":"CHEMBL104937","canonicalSmiles":"N=C(N)c1ccc2cc(C(=O)Nc3ccccc3)ccc2c1","inchiKey":"AECPTICWHONWNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL104937","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01977"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1093743","canonicalSmiles":"CCCCC/C=C\\C=C\\CCCCCCCCC(=O)O","inchiKey":"GKJZMAHZJGSBKD-NMMTYZSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1093743","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04746"],"chEBI":["44526"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1101","canonicalSmiles":"OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2","inchiKey":"YSXKPIUOCJLQIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIPERIDEN","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akineton"],"synonyms":["Akineton","Biperiden","KL 373"],"crossReferences":{"PubChem":["124894170","174006780","90341640"],"Wikipedia":["Biperiden"],"drugbank":["DB00810"],"chEBI":["3112"]},"childChemblIds":["CHEMBL1201035","CHEMBL1201067"],"count":6,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["EFO_0002610","MONDO_0002050","HP_0000726","EFO_0002508","MONDO_0043510","EFO_0005230","EFO_0000692"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and is indicated for parkinson's disease and has 5 investigational indications."}
{"id":"CHEMBL1118","canonicalSmiles":"CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1","inchiKey":"KYYIDSXMWOZKMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DESVENLAFAXINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desvenlafaxine","Khedezla","Pristiq"],"synonyms":["Desvenlafaxine","O-Desmethylvenlafaxine","ODV"],"crossReferences":{"DailyMed":["desvenlafaxine","desvenlafaxine%20succinate"],"Wikipedia":["Desvenlafaxine"],"drugbank":["DB06700"],"chEBI":["83527"]},"childChemblIds":["CHEMBL3989861","CHEMBL1201728"],"count":4,"approvedIndications":["MONDO_0002009","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_1000783","EFO_0004220","EFO_0005687","MONDO_0002050","EFO_0008623","EFO_1001892","MONDO_0002009","EFO_0003761","EFO_1001917","HP_0031217","EFO_0003922"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for unipolar depression and major depressive disorder and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL113051","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2/C=N/OC(C)(C)C","inchiKey":"UIVFUQKYVFCEKJ-OPTOVBNMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GIMATECAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gimatecan"],"crossReferences":{"PubChem":["170465615"],"drugbank":["DB06721"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1173532","canonicalSmiles":"COC[C@@]12CNCC[C@]1(c1ccc(Cl)c(Cl)c1)C2","inchiKey":"ICXJGCSEMJXNQF-ZIAGYGMSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-(3,4-dichlorophenyl)-6-(methoxymethyl)-3-azabicyclo[4.1.0]heptane (enantiomeric mix)"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL12","canonicalSmiles":"CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21","inchiKey":"AAOVKJBEBIDNHE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DIAZEPAM","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alupram 10","Alupram 2","Alupram 5","Apozepam","Atensine","Dialar","Dialar fte","Diastat","Diastat acudial","Diazepam","Diazepam intensol","Dizac","E-Pam","Paxel","Q-pam","Relanium","Scriptopam","Serenack","Solis","Stesolid","Tensium","Tranimul","Valclair","Valium","Valrelease","Valtoco","Vivol"],"synonyms":["Diazepam","Diazepam civ","LA III","LA-III","NRL-1","NSC-169897","NSC-77518","Nrl-1","RO 5-2807","RO-5-2807","RO-52807","WY-3467"],"crossReferences":{"DailyMed":["diazepam"],"PubChem":["124893574","144206622","144209656","170464626"],"TG-GATEs":["23"],"Wikipedia":["Diazepam"],"drugbank":["DB00829"],"chEBI":["49575"]},"childChemblIds":["CHEMBL543191"],"count":13,"approvedIndications":["EFO_0000474","EFO_0005230","HP_0000713"],"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000113327","ENSG00000151834","ENSG00000163285","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0008526","EFO_0005242","EFO_1000877","HP_0000726","EFO_0001358","HP_0001250","EFO_0003843","HP_0000713","EFO_0000546","EFO_0000474","MONDO_0002050","EFO_1000632","HP_0003419","EFO_0005279","EFO_0005230","EFO_0000692","EFO_1001250","EFO_1001010"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and has 3 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200380","canonicalSmiles":"Nc1nc([O-])c2ncn(COCCO)c2n1.[Na+]","inchiKey":"RMLUKZWYIKEASN-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ACYCLOVIR SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL184","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acyclovir","Acyclovir sodium","Zovirax"],"synonyms":["Aciclovir sodium","Acyclovir","Acyclovir sodium","Acyclovir sodium salt","BW 248U","BW 248U SODIUM","BW-248U SODIUM","BW-248U-SODIUM"],"crossReferences":{"DailyMed":["acyclovir%20sodium"]},"count":13,"approvedIndications":["EFO_0007282"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for genital herpes and has 12 investigational indications."}
{"id":"CHEMBL1200391","canonicalSmiles":"NC(CO)(CO)CO","inchiKey":"LENZDBCJOHFCAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROMETHAMINE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tham"],"synonyms":["NSC-6365","Trometamol","Tromethamine"],"crossReferences":{"DailyMed":["tromethamine"],"PubChem":["144208844","144213484","170464686","29215348","29215349"],"Wikipedia":["Tris"],"drugbank":["DB03754"],"chEBI":["9754"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and has 7 investigational indications."}
{"id":"CHEMBL1200458","canonicalSmiles":"O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[K+].[K+].[K+]","inchiKey":"QEEAPRPFLLJWCF-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM CITRATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Potassium Citrate","Urocit-K"],"synonyms":["E-332(II)","E332","INS NO.332(II)","INS-332(II)","Potassium citrate","Potassium citrate monohydrate"],"crossReferences":{"DailyMed":["potassium%20citrate"],"DrugCentral":["4519"],"Wikipedia":["Potassium_citrate"],"drugbank":["DB09125"],"chEBI":["64733"]},"childChemblIds":["CHEMBL3989822"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 2 investigational indications."}
{"id":"CHEMBL1200467","canonicalSmiles":"O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O.OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"ASDOKGIIKXGMNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYZINE PAMOATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL896","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["\"hy-pam \"\"25\"\"\"","Hy-Pam \"25\"","Hy-pam","Hydroxyzine pamoate","Vistaril"],"synonyms":["Hydroxyzine pamoate"],"crossReferences":{"DailyMed":["hydroxyzine%20pamoate"],"PubChem":["124886739","26748082","855631"],"chEBI":["31680"]},"count":4,"approvedIndications":["EFO_0005531","HP_0000989","EFO_0000701","EFO_0004257"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","HP_0000989","EFO_0000701","EFO_0004257"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 4 approved indications."}
{"id":"CHEMBL1200475","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"VNTHYLVDGVBPOU-QQYBVWGSSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DAUNORUBICIN CITRATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL178","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daunoxome"],"synonyms":["Daunorubicin citrate"],"count":3,"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","MONDO_0007254","EFO_0000691"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200560","canonicalSmiles":"CC(=O)O.N=C(N)N/N=C/c1c(Cl)cccc1Cl","inchiKey":"MCSPBPXATWBACD-GAYQJXMFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANABENZ ACETATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL420","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Guanabenz acetate","Wytensin"],"synonyms":["Guanabenz acetate","Guanabenz monoacetate","WY-8678","WY-8678 ACETATE"],"crossReferences":{"PubChem":["50106405"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200707","canonicalSmiles":"CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(C)=O.Cl","inchiKey":"KZLNXGBVFTWMPS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZQUINAMIDE HYDROCHLORIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201250","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emete-con"],"synonyms":["Benzquinamide HCl","Benzquinamide hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974."}
{"id":"CHEMBL1200790","canonicalSmiles":"CCC1(CC)C(=O)NCC(C)C1=O","inchiKey":"SIDLZWOQUZRBRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYPRYLON","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Noludar"],"synonyms":["Methyprylon"],"crossReferences":{"Wikipedia":["Methyprylon"],"drugbank":["DB01107"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200908","canonicalSmiles":"CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"BDSYKGHYMJNPAB-LICBFIPMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOBETASOL PROPIONATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bryhali","Halobetasol propionate","Lexette","Ultravate"],"synonyms":["BMY-30056","CGP-14,458","CGP-14458","Halobetasol propionate","Ulobetasol","Ulobetasol propionate"],"crossReferences":{"DailyMed":["halobetasol%20propionate"],"PubChem":["144206008"]},"count":2,"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000676","EFO_0000274"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 2 investigational indications."}
{"id":"CHEMBL1201001","canonicalSmiles":"CN(CCCl)CCCl.Cl","inchiKey":"QZIQJVCYUQZDIR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MECHLORETHAMINE HYDROCHLORIDE","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL427","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mustargen","Valchlor"],"synonyms":["Chlormethine hydrochloride","Hn2 hydrochloride","Mechlorethamine hydrochloride","Mustine","NSC-762","Nitrogen mustard","Nitrogen mustard n-oxide hydrochloride"],"crossReferences":{"DailyMed":["mechlorethamine%20hydrochloride"],"PubChem":["144204721","144207836","170465017","17388852","538248"],"chEBI":["55368"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1949 and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201066","canonicalSmiles":"COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1.Cl","inchiKey":"QYRYFNHXARDNFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VENLAFAXINE HYDROCHLORIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL637","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Effexor","Effexor xr","Venlafaxine hydrochloride"],"synonyms":["Venlafaxine hydrochloride","WY-45,030","WY-45030"],"crossReferences":{"DailyMed":["venlafaxine%20hydrochloride"],"PubChem":["144212825","49681556"],"chEBI":["9944"]},"count":23,"approvedIndications":["MONDO_0002050","MONDO_0002009","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0006862","EFO_0002610","EFO_0004262","EFO_0005687","MONDO_0002009","HP_0000726","EFO_0000249","MONDO_0007254","EFO_1001919","EFO_1001917","HP_0031217","EFO_0000289","MONDO_0002050","EFO_0000673","EFO_0003761","EFO_0009854","EFO_0004242","EFO_0005230","EFO_0000692","EFO_0005762","EFO_0002508","EFO_0003821","EFO_0001358","MONDO_0008315","EFO_1001892","HP_0030833","MONDO_0043510","EFO_0003918"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 3 approved and 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201091","canonicalSmiles":"COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC.Cl.O","inchiKey":"MWYNOTLRCUQCKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERAZOSIN HYDROCHLORIDE HYDRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL611","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hytrin","Terazosin HCl"],"synonyms":["Terazosin HCl"],"crossReferences":{"PubChem":["26719771"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201237","canonicalSmiles":"CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O","inchiKey":"IXHBTMCLRNMKHZ-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOBUNOLOL","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Levobunolol"],"crossReferences":{"DailyMed":["levobunolol%20hydrochloride"],"PubChem":["11112712","11112713"],"Wikipedia":["Levobunolol"],"drugbank":["DB01210"],"chEBI":["6438"]},"childChemblIds":["CHEMBL1201177"],"count":1,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0000516"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and is indicated for glaucoma."}
{"id":"CHEMBL1222251","canonicalSmiles":"O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O","inchiKey":"CDAISMWEOUEBRE-GPIVLXJGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INOSITOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyclohexanehexol","Inositol","Meso-inositol","NSC-25142","NSC-404118","NSC-55551","NSC-8101"],"crossReferences":{"PubChem":["144205195","144212352","170465541","29215342","56324719","73813"],"Wikipedia":["Inositol"],"drugbank":["DB13178"],"chEBI":["17268"]},"count":10,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL1230365","canonicalSmiles":"COc1cc(C(C)(C)C#Cc2c(C)nc(N)nc2N)cc(OC)c1OC","inchiKey":"FJNFXXGWYVMQNA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230365","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07153"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230617","canonicalSmiles":"Nc1ncnc2c1nc(Br)n2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"DNPIJKNXFSPNNY-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"8-Bromo-Adenosine Mono Phosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8-Bromo-Adenosine Mono Phosphate"],"crossReferences":{"drugbank":["DB03349"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231193","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)N[C@@H](C(Cl)Cl)NS2(=O)=O","inchiKey":"LMJSLTNSBFUCMU-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231193","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112292"],"drugbank":["DB08645"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231644","canonicalSmiles":"C[As](C)(=O)O","inchiKey":"OGGXGZAMXPVRFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CACODYLIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211084","26747794","26753706","29215173","405276","93576721"],"drugbank":["DB02994"],"chEBI":["48765"]},"childChemblIds":["CHEMBL2079844","CHEMBL1877702"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233024","canonicalSmiles":"Fc1ccc(-c2n[nH]cc2-c2ccncc2)cc1","inchiKey":"BILJSHVAAVZERY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233024","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07829"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233772","canonicalSmiles":"O=C(CN(CCO)S(=O)(=O)c1ccc(-c2ccccc2)cc1)NO","inchiKey":"QQDWEVONJRXVDB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233772","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08029"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236235","canonicalSmiles":"Cc1ncc(C[n+]2csc(CCOP(=O)([O-])OP(=O)(O)O)c2C)c(N)n1","inchiKey":"AYEKOFBPNLCAJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAMIN DIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thiamin Diphosphate"],"crossReferences":{"drugbank":["DB01987"],"chEBI":["45931"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236302","canonicalSmiles":"N[C@@H](Cc1cccs1)C(=O)O","inchiKey":"WTOFYLAWDLQMBZ-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236302","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03673"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236595","canonicalSmiles":"COC1=C(OC)C(=O)C(C/C=C(\\C)CCC=C(C)C)=C(C)C1=O","inchiKey":"SQQWBSBBCSFQGC-JLHYYAGUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Coenzyme Q2","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08690"],"chEBI":["46372"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237","canonicalSmiles":"NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O","inchiKey":"RLAWWYSOJDYHDC-BZSNNMDCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LISINOPRIL","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prinivil","Zestril"],"synonyms":["Lisinopril","Lisinopril dihydrate","Lisinopril hydrate","MK-521"],"crossReferences":{"DailyMed":["lisinopril"],"PubChem":["50085996"],"Wikipedia":["Lisinopril"],"drugbank":["DB00722"],"chEBI":["43755"]},"childChemblIds":["CHEMBL419213","CHEMBL1729579"],"count":23,"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000401","MONDO_0007254","EFO_1001249","EFO_0000373","MONDO_0002462","EFO_1000948","EFO_1002034","EFO_0003914","Orphanet_416","EFO_0002690","EFO_1001375","EFO_0000279","EFO_0003144","EFO_0000712","EFO_1002032","EFO_0000400","EFO_0008620","HP_0003124","EFO_0001645","EFO_0004236","EFO_0000319","EFO_0004194","EFO_0000537","EFO_0003896","Orphanet_79292","EFO_0000764","EFO_0000574","EFO_0000612","EFO_0001360","HP_0012594","EFO_0004264"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 23 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1256646","canonicalSmiles":"Br.Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1","inchiKey":"DSGOSRLTVBPLCU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOLDOPAM BROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL588","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenoldopam Bromide"],"crossReferences":{"PubChem":["50106351","57264385"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL12610","canonicalSmiles":"CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12","inchiKey":"CNBGNNVCVSKAQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZYDAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benzydamine"],"crossReferences":{"PubChem":["11112291","160657813"],"Wikipedia":["Benzydamine"],"drugbank":["DB09084"]},"childChemblIds":["CHEMBL1528134"],"count":5,"approvedIndications":["HP_0002829","HP_0003326","EFO_0005755","EFO_0005757"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["HP_0002829","HP_0003326","EFO_1001216","EFO_0009688","MONDO_0002258","EFO_0003843","EFO_0005755","EFO_0005757","EFO_1001904"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 approved and 1 investigational indication."}
{"id":"CHEMBL129857","canonicalSmiles":"COc1cccc2nc(-c3cccs3)nc(NN3C(=O)C=C(C)C3=O)c12","inchiKey":"GZGLPBNOIFLLRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AS-602868","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["As-602868","SPC-839"],"crossReferences":{"PubChem":["137275813","26755375"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1315867","canonicalSmiles":"CC(C)(C)NCC(O)c1cc(O)cc(O)c1.CC(C)(C)NCC(O)c1cc(O)cc(O)c1.O=S(=O)(O)O","inchiKey":"KFVSLSTULZVNPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TERBUTALINE SULFATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1760","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brethaire","Brethine","Bricanyl","Bricanyl sa","Monovent","Monovent sa","Terbasmin","Terbutaline sulfate"],"synonyms":["KWD 2019","KWD-2019","Terbutaline sulfate","Terbutaline sulphate"],"crossReferences":{"DailyMed":["terbutaline%20sulfate"],"PubChem":["144204153","170464990","50107039"]},"count":2,"approvedIndications":["EFO_0000270"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for asthma and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL132376","canonicalSmiles":"OC[C@H]1O[C@@H](S)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"JUSMHIGDXPKSID-DVKNGEFBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL132376","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03859"],"chEBI":["42896"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1382","canonicalSmiles":"Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1","inchiKey":"OOGJQPCLVADCPB-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLTERODINE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Blerone xl","Detrusitol","Detrusitol xl","Efflosomyl xl","Inconex xl","Mariosea xl","Neditol xl","Preblacon xl","Santizor xl"],"synonyms":["KABI 2234","KABI-2234","Tolterodine"],"crossReferences":{"DailyMed":["tolterodine%20tartrate"],"PubChem":["144205290","170465337","29215497","49666284"],"Wikipedia":["Tolterodine"],"drugbank":["DB01036"],"chEBI":["9622"]},"childChemblIds":["CHEMBL1200871","CHEMBL1722209"],"count":7,"approvedIndications":["HP_0000020","HP_0000103"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","HP_0012532","HP_0006000","EFO_0004253","EFO_0006865","HP_0000020","EFO_1000781","HP_0003419","EFO_0000284","EFO_0003843","EFO_0004710","HP_0000103"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for polyuria and urinary incontinence and has 5 investigational indications."}
{"id":"CHEMBL141305","canonicalSmiles":"CC(=O)Oc1ccc(C(=C2CCCCC2)c2ccc(OC(C)=O)cc2)cc1","inchiKey":"GVOUFPWUYJWQSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOFENIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hepatotoxicity"],"year":1987},"tradeNames":["Neoclym","Rehibin"],"synonyms":["Cyclofenil","F 6066","ICI 48213"],"crossReferences":{"PubChem":["144205812","170465970","29217524"],"drugbank":["DB13472"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1987 due to Hepatotoxicity."}
{"id":"CHEMBL1446","canonicalSmiles":"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O.O=S(=O)(O)O","inchiKey":"OOYGSFOGFJDDHP-KMCOLRRFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KANAMYCIN SULFATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1384","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kanamycin sulfate","Kantrex","Klebcil"],"synonyms":["Kanamycin a sulfate","Kanamycin monosulfate","Kanamycin sulfate"],"crossReferences":{"PubChem":["121269829","144204163","144210015"],"chEBI":["6109"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 2 investigational indications."}
{"id":"CHEMBL1478530","canonicalSmiles":"CC[C@H](NC(C)C)[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12","inchiKey":"FKNXQNWAXFXVNW-BLLLJJGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1478530","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113915","144204492","170465820","26752069"],"drugbank":["DB01366"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1527608","canonicalSmiles":"Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O","inchiKey":"HWXIGFIVGWUZAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXOFYLLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Maxivent"],"synonyms":["ABC 12/3","Doxofylline","Doxophylline"],"crossReferences":{"PubChem":["144205130","170466312","29215238","49645880"],"drugbank":["DB09273"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1529","canonicalSmiles":"Cl.OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1","inchiKey":"AVZIYZHXZAYGJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENIDOL HYDROCHLORIDE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL936","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vontrol"],"synonyms":["Diphenidol hydrochloride","SK&F 478-A","SK-478-A"],"crossReferences":{"PubChem":["11533019","85273789"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1967."}
{"id":"CHEMBL155572","canonicalSmiles":"NCc1ccccc1O","inchiKey":"KPRZOPQOBJRYSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Aminomethyl-Phenol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Aminomethyl-Phenol"],"crossReferences":{"drugbank":["DB14855"]},"childChemblIds":["CHEMBL3114402"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL15677","canonicalSmiles":"O=C(O)Cc1ccccc1Oc1ccc(Cl)cc1Cl","inchiKey":"IDKAXRLETRCXKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENCLOFENAC","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Carcinogenicity"," Dermatological toxicity"],"year":1984},"tradeNames":[],"synonyms":["Fenclofenac","R 67408","RX 67408"],"crossReferences":{"PubChem":["144206863"],"Wikipedia":["Fenclofenac"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1978. It was withdrawn in United Kingdom  in 1984 due to Carcinogenicity and  Dermatological toxicity."}
{"id":"CHEMBL1614","canonicalSmiles":"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@]4(C)[C@H]5C[C@@H](O)[C@]6(C)[C@@H](C7=CC(=O)OC7)CC[C@]6(O)[C@@H]5CC[C@@H]4C3)O[C@@H]2C)C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](C)O1","inchiKey":"OBATZBGFDSVCJD-LALPQLPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESLANOSIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cedilanid-d"],"synonyms":["Desacetyl-lanatoside c","Deslanoside"],"crossReferences":{"PubChem":["144205224","170465236"],"Wikipedia":["Deslanoside"],"drugbank":["DB01078"],"chEBI":["31468"]},"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000163399","ENSG00000018625","ENSG00000105409","ENSG00000132681"],"count":4},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1685","canonicalSmiles":"C[C@@]12CCCCC[C@@H](Cc3ccc(O)cc31)[C@@H]2N","inchiKey":"VTMVHDZWSFQSQP-VBNZEHGJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEZOCINE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dalgan"],"synonyms":["Dezocine","WY-16,225","WY-16225"],"crossReferences":{"Wikipedia":["Dezocine"],"drugbank":["DB01209"],"chEBI":["4474"]},"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000112038"],"count":2},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989 and is indicated for pain."}
{"id":"CHEMBL16958","canonicalSmiles":"O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21","inchiKey":"MEXUTNIFSHFQRG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STAUROSPORINONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["K-252C"],"crossReferences":{"PubChem":["50112993"],"drugbank":["DB08036"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1723343","canonicalSmiles":"Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"NYVVVBWEVRSKIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOLPIDEM TARTRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL911","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ambien Cr","Edluar","Intermezzo","Tovalt Odt","Zolpidem Tartrate","Zolpimist"],"synonyms":["SL-80.0750-23N"],"crossReferences":{"PubChem":["49681561"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1742428","canonicalSmiles":"N#Cc1ccc(N2CCN(C(=O)COc3ccc4[nH]cc(CCN)c4c3)CC2)cc1","inchiKey":"SOHCKWZVTCTQBG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DONITRIPTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Donitriptan","F-11356"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1742466","canonicalSmiles":"CC1(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)cc2)O1","inchiKey":"WMDSZGFJQKSLLH-RBBKRZOGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANDIOLOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AOP-200704","AOP200704","LDLL-600","LDLL600","Landiolol","ONO-1101"],"crossReferences":{"drugbank":["DB12212"]},"childChemblIds":["CHEMBL2362410"],"count":3,"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004269","EFO_0000319"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1743043","drugType":"Antibody","blackBoxWarning":true,"name":"MOXETUMOMAB PASUDOTOX","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lumoxiti"],"synonyms":["CAT-8015","HA-22","HA22","Moxetumomab pasudotox","Moxetumomab pasudotox-tdfk"],"crossReferences":{"DailyMed":["moxetumomab%20pasudotox-tdfk"]},"count":7,"approvedIndications":["EFO_1000956"],"linkedTargets":{"rows":["ENSG00000167658","ENSG00000012124"],"count":2},"linkedDiseases":{"rows":["EFO_0000565","EFO_1000956","EFO_0000095","EFO_0000220","EFO_0000574","MONDO_0000870","EFO_0005952"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for hairy cell leukemia and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1743060","drugType":"Antibody","blackBoxWarning":false,"name":"RADRETUMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Radretumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743085","drugType":"Antibody","blackBoxWarning":false,"name":"URELUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-663513","Urelumab"],"count":10,"linkedTargets":{"rows":["ENSG00000049249"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000616","EFO_0002618","EFO_0000096","EFO_0000756","EFO_1001465","EFO_0001378","EFO_0005952","EFO_0003060","EFO_0000311"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL175","canonicalSmiles":"CC(C)Cc1ccc([C@H](C)C(=O)O)cc1","inchiKey":"HEFNNWSXXWATRW-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXIBUPROFEN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Seractil"],"synonyms":["Dexibuprofen","IBU-TAB","Neoprofen","Rufen"],"crossReferences":{"PubChem":["11111293","11111294","11112775","144206692","47193724","50100253","50106464","85231335","90340840"],"Wikipedia":["Dexibuprofen"],"drugbank":["DB09213"],"chEBI":["43415"]},"childChemblIds":["CHEMBL1778537"],"count":3,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_1000786","HP_0001945","EFO_0004616","EFO_0003843","EFO_0005755"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 2 investigational indications."}
{"id":"CHEMBL1779710","canonicalSmiles":"CC(C)(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F","inchiKey":"LCDDAGSJHKEABN-MLGOLLRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EVOGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DA-1229","Da-1229","Evogliptin"],"crossReferences":{"drugbank":["DB12625"]},"count":4,"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","HP_0001410","EFO_0001360","EFO_0000400"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1800955","canonicalSmiles":"COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1","inchiKey":"RFUBTTPMWSKEIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMECAMTIV MECARBIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CK-1827452","Omecamtiv mecarbil"],"crossReferences":{"PubChem":["174007336"],"drugbank":["DB11816"]},"count":1,"linkedTargets":{"rows":["ENSG00000197616","ENSG00000160808","ENSG00000111245","ENSG00000106631","ENSG00000078814","ENSG00000092054","ENSG00000198336"],"count":7},"linkedDiseases":{"rows":["HP_0012664","EFO_0003144"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL182260","canonicalSmiles":"NS(=O)(=O)c1ccc(Nc2cn3cc(C(=O)c4c(Cl)cccc4Cl)ccc3n2)cc1","inchiKey":"UQAWGIKJINAKIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL182260","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04607"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1829335","canonicalSmiles":"C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)[nH]n2)cc1","inchiKey":"XUKROCVZGZNGSI-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IRDABISANT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CEP-26401","Irdabisant"],"crossReferences":{"drugbank":["DB12900"]},"childChemblIds":["CHEMBL1813067"],"count":1,"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["HP_0100543"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1865134","canonicalSmiles":"CC(C)(C)c1ccc2c(S(=O)(=O)O)c(C(C)(C)C)ccc2c1","inchiKey":"WBEBQCINXJDZCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBUNIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dibunate"],"crossReferences":{"PubChem":["124893716","50125928"],"drugbank":["DB13796"]},"childChemblIds":["CHEMBL2107554"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL190201","canonicalSmiles":"COc1ccc(-c2oc3ncnc(NCCO)c3c2-c2ccc(OC)cc2)cc1","inchiKey":"ARBUGBBNEFAECO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL190201","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08392"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908108","canonicalSmiles":"CC[C@@H]([C@H](C)O)n1n[14cH]n(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O","inchiKey":"RAGOYPUPXAKGKH-RMNHMKCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"C-posaconazole","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1397","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C-posaconazole"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908361","canonicalSmiles":"Nc1nc(=O)c2c([nH]1)NC[C@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1)N2C=O.[Ca+2]","inchiKey":"KVUAALJSMIVURS-QNTKWALQSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOLEUCOVORIN CALCIUM","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1908841","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fusilev","Levoleucovorin calcium"],"synonyms":["CL 307,782","CL-307782","Calcium levofolinate","Folinic acid l-form calcium salt","Levofolinate calcium","Levoleucovorin calcium"],"crossReferences":{"DailyMed":["levoleucovorin%20calcium"]},"count":7,"approvedIndications":["EFO_0000637","EFO_0000365"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for osteosarcoma and colorectal adenocarcinoma and has 5 investigational indications."}
{"id":"CHEMBL1908372","canonicalSmiles":"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@]2(OC)C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@@H]32)[C@H](C)O)C(=O)C1=O","inchiKey":"SMSRCGPDNDCXFR-CYWZMYCQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFBUPERAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMY-25182","Cefbuperazone","Cefbuperazone sodium","T-1982"],"crossReferences":{"drugbank":["DB13638"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL19224","canonicalSmiles":"COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC","inchiKey":"XQYZDYMELSJDRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAPAVERINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-136630","Papaverine"],"crossReferences":{"PubChem":["11111623","11111624","11111625","124881091","50104295","90341237"],"TG-GATEs":["98"],"Wikipedia":["Papaverine"],"drugbank":["DB01113"],"chEBI":["28241"]},"childChemblIds":["CHEMBL98123"],"count":5,"approvedIndications":["EFO_0010282","EFO_0004234"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for erectile dysfunction and gastrointestinal disease and has 3 investigational indications."}
{"id":"CHEMBL195836","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O","inchiKey":"BTTWKVFKBPAFDK-LOVVWNRFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL195836","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["4-Androstenediol"],"drugbank":["DB01526"],"chEBI":["34386"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL206646","canonicalSmiles":"O=C(/C=C/c1ccc(O)c(O)c1)NCCc1ccc(O)cc1","inchiKey":"VSHUQLRHTJOKTA-XBXARRHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Trans-N-Caffeoyltyramine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trans-N-Caffeoyltyramine"],"crossReferences":{"drugbank":["DB08754"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2074725","canonicalSmiles":"CC(=O)O[C@H]1C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)O[C@H](C)[C@H]1O","inchiKey":"HWKJSYYYURVNQU-DXJNJSHLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLDIGOXIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetyldigoxin","beta-Acetyldigoxin"],"crossReferences":{"drugbank":["DB13691"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2074932","canonicalSmiles":"O=CC[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"VRYALKFFQXWPIH-PBXRRBTRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYGLUCOSE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08831"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103761","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1","inchiKey":"VXMOONUMYLCFJD-DHLKQENFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BARNIDIPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Barnidipine","Barnidipine hydrochloride"],"crossReferences":{"drugbank":["DB09227"]},"childChemblIds":["CHEMBL2356712"],"count":1,"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104154","canonicalSmiles":"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1cccc2nonc12","inchiKey":"QERUYFVNIOLCHV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARODIPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Darodipine","PY 108-068"],"crossReferences":{"drugbank":["DB09234"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104457","canonicalSmiles":"CC(=O)NC1CCSC1=O","inchiKey":"NRFJZTXWLKPZAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CITIOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Citiolone"],"crossReferences":{"PubChem":["144204941","144206897","170466625"],"drugbank":["DB13442"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105902","canonicalSmiles":"COc1ccc([N-]S(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1F.[Na+]","inchiKey":"UWPXRVDIKGZQQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BATABULIN SODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL79280","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Batabulin sodium","T-138067 SODIUM","T138067-SODIUM"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105910","canonicalSmiles":"CC(COc1ccccc1Cc1ccccc1)N1CCCCC1","inchiKey":"JTUQXGZRVLWBCR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENPROPERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASA 158/5 [AS PHOSPHATE]","Benproperine","Benproperine phosphate"],"crossReferences":{"drugbank":["DB13309"]},"childChemblIds":["CHEMBL4544020"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105949","canonicalSmiles":"COc1ccc(-c2sc3cc(O)ccc3c2Oc2ccc(OCCN3CCCCC3)cc2)cc1.Cl","inchiKey":"NHSNLUIMAQQXGR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARZOXIFENE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL226267","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arzoxifene hydrochloride","LY-353381.HCL","LY353381.HCL","SERM 3","SERM-3"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2106083","canonicalSmiles":"C[N+](C)(C)CCOC(Cc1ccccc1)c1ccccc1.[Br-]","inchiKey":"APVMLVNTOWQOHL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BIBENZONIUM BROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110796","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bibenzonium bromide"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106284","canonicalSmiles":"CCOC(=O)C(CCN1CCOCC1)(c1ccccc1)c1ccccc1","inchiKey":"LQGIXNQCOXNCRP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIOXAPHETYL BUTYRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dioxaphetyl butyrate"],"crossReferences":{"drugbank":["DB01475"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107354","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC.O.[Na+]","inchiKey":"SARBMGXGWXCXFW-GJHVZSAVSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"MIFAMURTIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2111100","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CGP-19835","L-MTP-PE","Mifamurtide","Mifamurtide sodium hydrate","Mifamurtide sodium salt monohydrate"],"count":1,"linkedTargets":{"rows":["ENSG00000167207"],"count":1},"linkedDiseases":{"rows":["EFO_0000637"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2108667","drugType":"Antibody","blackBoxWarning":true,"name":"YTTRIUM Y 90 IBRITUMOMAB TIUXETAN","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BAY-86-5128","Ibritumomab tiuxetan","Yttrium y 90 ibritumomab tiuxetan"],"count":18,"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","MONDO_0013730","MONDO_0000873","MONDO_0019465","MONDO_0044887","EFO_0000403","EFO_1001469","EFO_0005952","EFO_0000565","EFO_0000309","EFO_1001365","EFO_0003032","EFO_0000096","EFO_0000095","MONDO_0019088","EFO_1000630","EFO_0000191","EFO_0000574","EFO_0001378","MONDO_0018906","EFO_0000183","EFO_1000550"],"count":22},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 18 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108739","drugType":"Antibody","blackBoxWarning":false,"name":"PLACULUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ART-621","ART-621 ( ANTI-TUMOUR NECROSIS FACTOR ALPHA ANTIBODY)","ART621","CEP-37247","PN-0621","PN0621","Placulumab"],"count":2,"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","HP_0011868"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108813","drugType":"Unknown","blackBoxWarning":false,"name":"WAX, EMULSIFYING","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Buff","Coconut oil","Emulfin","Emulsif","Epaderm","H.e.b.","Lanette wax","Lanette wax sx"],"synonyms":["Emulsifying wax","Wax, emulsifying"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2108981","drugType":"Unknown","blackBoxWarning":false,"name":"ANTILYMPHOCYTE IMMUNOGLOBULIN (HORSE)","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antilymphocyte immunoglobulin (horse)"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109150","drugType":"Antibody","blackBoxWarning":false,"name":"LINTUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zamyl"],"synonyms":["HUM-195","HUM195","Huma-195-Gelonin","Lintuzumab","SGN-33"],"count":7,"linkedTargets":{"rows":["ENSG00000105383"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000198","EFO_0004251","EFO_1001779","MONDO_0001475","EFO_0000222","EFO_0001378"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2109265","drugType":"Antibody","blackBoxWarning":false,"name":"MOC31-PE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MOC31-PE","Moc31-pe"],"count":1,"linkedTargets":{"rows":["ENSG00000119888"],"count":1},"linkedDiseases":{"rows":["EFO_0000313"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109365","drugType":"Antibody","blackBoxWarning":false,"name":"HUPAM4","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUPAM4"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109401","drugType":"Antibody","blackBoxWarning":false,"name":"AV-203","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AV-203","AV203","Av 203","Av-203","CAN-017"],"count":1,"linkedTargets":{"rows":["ENSG00000065361"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109592","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-500","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-500","Medi-500","T10B9"],"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2109593","drugType":"Antibody","blackBoxWarning":false,"name":"FGI-101-1A6","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FGI-101-1A6","Fgi-101-1a6"],"count":1,"linkedTargets":{"rows":["ENSG00000074319"],"count":1},"linkedDiseases":{"rows":["EFO_0007328"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL216647","canonicalSmiles":"CC(C)(NC(=O)c1ccc2c(C3CCCCC3)c3n(c2c1)CCOc1ccccc1-3)C(=O)O","inchiKey":"LNQWELVSNCYKDU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL216647","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08031"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL219321","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OS(N)(=O)=O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"YXYXCSOJKUAPJI-ZBRFXRBCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E2MATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Estradiol-3-O-Sulfamate"],"crossReferences":{"drugbank":["DB06597"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2218898","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCSCC[C@@H](C(=O)N(C)[C@H](CO)CCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O","inchiKey":"UGNGRKKDUVKQDF-IHOMMZCZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BARUSIBAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Barusiban","Fe-200440"],"crossReferences":{"drugbank":["DB12292"]},"count":1,"linkedTargets":{"rows":["ENSG00000180914"],"count":1},"linkedDiseases":{"rows":["EFO_0000545"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL229264","canonicalSmiles":"Cc1c(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1Cl","inchiKey":"KEJORAMIZFOODM-PWSUYJOCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-564929","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-564929"],"crossReferences":{"drugbank":["DB07286"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL230011","canonicalSmiles":"Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1","inchiKey":"UJIAQDJKSXQLIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TG100-115","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TG100-115","Tg100-115"],"crossReferences":{"drugbank":["DB05552"]},"count":1,"linkedTargets":{"rows":["ENSG00000171608","ENSG00000105851"],"count":2},"linkedDiseases":{"rows":["EFO_0000612"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL25336","canonicalSmiles":"C(=N/NC1=NCCN1)\\c1c2ccccc2c(/C=N/NC2=NCCN2)c2ccccc12","inchiKey":"NJSMWLQOCQIOPE-OCHFTUDZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BISANTRENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bisantrene","NSC-337766"],"childChemblIds":["CHEMBL3989424"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL267345","canonicalSmiles":"C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2","inchiKey":"APKFDSVGJQXUKY-INPOYWNPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMPHOTERICIN B","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abelcet","Ambisome","Amophotericin B","Ampho-moronal","Amphotec","Amphotercin B","Amphotericin b","Amphotericine B","Amphotericitin B","Amphotreicin B","Ampotericin B","Fungilin","Fungilin in orabase","Fungizone"],"synonyms":["Amphotericin","Amphotericin b","Amphotericin b deoxycholate","Amphotericin b lipid complex","Amphotericin b liposomal complex","Amphotericin b, liposome","NSC-527017"],"crossReferences":{"DailyMed":["amphotericin%20b"],"PubChem":["144204578","144209682","17389549"],"Wikipedia":["Amphotericin_B"],"drugbank":["DB00681"],"chEBI":["2682"]},"count":27,"approvedIndications":["EFO_0007228","EFO_0007310","EFO_0000544","EFO_0007157","EFO_0007380","MONDO_0002041","EFO_0007494","EFO_0005045","EFO_0007229","MONDO_0002026"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 10 approved and 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL270362","canonicalSmiles":"CCCc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)OC(C)C(C)C3O","inchiKey":"NIDRYBLTWYFCFV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALANOLIDE A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calanolide a","NSC-650886"],"crossReferences":{"PubChem":["26665012"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL276711","canonicalSmiles":"Cc1cc(C)c(/C=C2\\C(=O)Nc3ccccc32)[nH]1","inchiKey":"WUWDLXZGHZSWQZ-WQLSENKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEMAXANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-696819","SU-5416","SU005416","SU5416","Semaxanib","Semaxinib","Su-5416"],"crossReferences":{"PubChem":["124891688","49674962","50107014","50107016","525180","56322916","90341564"],"Wikipedia":["Semaxanib"],"drugbank":["DB06436"]},"count":17,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000157404"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_0006859","EFO_0000365","EFO_0000756","EFO_0000681","MONDO_0007254","EFO_1000657","MONDO_0021063","MONDO_0008315","EFO_1001951","EFO_0000588","MONDO_0002974","EFO_0000389","MONDO_0002367","EFO_0001378","EFO_0000691","EFO_1000158"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 17 investigational indications."}
{"id":"CHEMBL289288","canonicalSmiles":"C[C@](O)(C(=O)Nc1cccc2c1C(=O)c1sccc1CS2(=O)=O)C(F)(F)F","inchiKey":"NAFSYPCVPLWHFY-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL289288","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05498"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL293492","canonicalSmiles":"O=C/C=C/c1ccccc1","inchiKey":"KJPRLNWUNMBNBZ-QPJJXVBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINNAMALDEHYDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cinnamaldehyde","Cinnamic aldehyde"],"crossReferences":{"PubChem":["144204695","144209002","144213588","17389103","17389104","29215112","85272553"],"Wikipedia":["Cinnamaldehyde"],"drugbank":["DB14184"],"chEBI":["16731"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL303992","canonicalSmiles":"N=C(N)c1ccc2[nH]c(-c3cccc(OC4CCCC4)c3O)nc2c1","inchiKey":"WCFWDBPDMBXMTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL303992","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02526"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL308745","canonicalSmiles":"CCCCN/C(N)=N/O","inchiKey":"ULDDTFAPYWLDGF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL308745","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02727"]},"childChemblIds":["CHEMBL2398455"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137301","canonicalSmiles":"CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O","inchiKey":"PYNXFZCZUAOOQC-UTKZUKDTSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SACUBITRIL","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AHU-377","AHU377","Sacubitril"],"crossReferences":{"DailyMed":["sacubitril"],"drugbank":["DB09292"]},"count":4,"approvedIndications":["EFO_0003144","EFO_0000373"],"linkedTargets":{"rows":["ENSG00000196549"],"count":1},"linkedDiseases":{"rows":["HP_0012664","EFO_0003144","EFO_0008583","EFO_0000373","EFO_1001207","EFO_0000612","EFO_0000538","HP_0031273","EFO_0000537"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for heart failure and congestive heart failure and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL316053","canonicalSmiles":"Nc1nccc2ccc(CN3CC[C@H](NS(=O)(=O)c4cc5ncccc5s4)C3=O)cc12","inchiKey":"NVKDOURNRJCKJE-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL316053","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07261"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186864","canonicalSmiles":"CCCCCCC(O)CO","inchiKey":"AEIJTFQOBWATKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186864","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211336"],"drugbank":["DB14589"],"chEBI":["34056"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL320775","canonicalSmiles":"Cc1ccc2nc(N)[nH]c(=O)c2c1Sc1ccncc1","inchiKey":"XHWRWCSCBDLOLM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOLATREXED","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nolatrexed"],"crossReferences":{"PubChem":["50125758"],"drugbank":["DB12912"]},"childChemblIds":["CHEMBL1983788","CHEMBL2356692"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3275971","canonicalSmiles":"CC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"ILCTUFVQFCIIDS-NGFSFWIMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3275971","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13951"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL334966","canonicalSmiles":"CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"PAEBIVWUMLRPSK-IDTAVKCVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANGRELOR","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AR-C69931XX","Cangrelor"],"crossReferences":{"DailyMed":["cangrelor"],"drugbank":["DB06441"]},"childChemblIds":["CHEMBL1097279"],"count":3,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0008585","EFO_0001645","EFO_0000556","EFO_0008583","GO_0070527","HP_0004419","EFO_0000612","HP_0031273","EFO_0005672"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for recurrent thrombophlebitis and has 2 investigational indications."}
{"id":"CHEMBL35033","canonicalSmiles":"CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O","inchiKey":"MLILORUFDVLTSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMIVIRINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Coactinon"],"synonyms":["Emivirine","MKC-442"],"crossReferences":{"Wikipedia":["Emivirine"],"drugbank":["DB08188"],"chEBI":["44143"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545062","canonicalSmiles":"COC[C@H]1C[C@@H](c2nc(-c3ccc4c(c3)COc3cc5c(ccc6nc([C@@H]7CC[C@H](C)N7C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c65)cc3-4)c[nH]2)N(C(=O)[C@H](NC(=O)OC)c2ccccc2)C1","inchiKey":"FHCUMDQMBHQXKK-CDIODLITSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VELPATASVIR","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GS-5816","Velpatasvir"],"crossReferences":{"DailyMed":["velpatasvir"],"drugbank":["DB11613"]},"count":3,"approvedIndications":["EFO_0004220"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for chronic hepatitis c virus infection and has 2 investigational indications."}
{"id":"CHEMBL3545092","drugType":"Small molecule","blackBoxWarning":false,"name":"CR 1447","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cr 1447"],"linkedTargets":{"rows":["ENSG00000140009","ENSG00000169083"],"count":2},"linkedDiseases":{"rows":["EFO_0000304"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545408","canonicalSmiles":"O=C1c2ccccc2C(=O)N1[C@@H]1CC[C@@]2(O)C3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)C1O5","inchiKey":"DHAITNWJDOSRBU-RCSSWNHXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALTALIMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Naltalimide","TAK363","Trk-130"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545420","canonicalSmiles":"CCNCc1cncc(-c2ccc3c(c2)/C(=C2/N=c4cc(F)cc(F)c4=N2)NN3)c1C","inchiKey":"RBOKLZGCVRXGEP-XTQSDGFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AG-24322","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG-024322","Ag 024322","Ag-24322"],"count":1,"linkedTargets":{"rows":["ENSG00000123374","ENSG00000135446","ENSG00000170312"],"count":3},"linkedDiseases":{"rows":["EFO_0005952"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545426","drugType":"Small molecule","blackBoxWarning":false,"name":"CC-115","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cc-115"],"count":6,"linkedTargets":{"rows":["ENSG00000253729","ENSG00000198793"],"count":2},"linkedDiseases":{"rows":["EFO_0000637","EFO_0000095","MONDO_0008315","EFO_0000181","EFO_0000519","EFO_0009708"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL35505","canonicalSmiles":"NNc1nnc(NN)c2ccccc12","inchiKey":"VQKLRVZQQYVIJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDRALAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dihydralazine","NSC-526654"],"crossReferences":{"PubChem":["144205206","170466387","29215360"],"Wikipedia":["Dihydralazine"],"drugbank":["DB12945"]},"childChemblIds":["CHEMBL2106266"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3559670","drugType":"Small molecule","blackBoxWarning":false,"name":"LYAPOLATE SODIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Peson"],"synonyms":["Lyapolate sodium","Sodium apolate","Sodium polyethylenesulfonate"],"crossReferences":{"DrugCentral":["4705"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL357217","canonicalSmiles":"COC1=CC(=O)c2c(c(COc3ccc([N+](=O)[O-])cc3)c(C)n2C)C1=O","inchiKey":"IBLWSLZYYZHSRG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ES-936","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ES-936"],"crossReferences":{"drugbank":["DB02400"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3586469","canonicalSmiles":"O=C([O-])c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1.[Na+]","inchiKey":"CPUPAOAXNTYRQJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3586469","maximumClinicalTrialPhase":0,"parentId":"CHEMBL259084","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3681949","canonicalSmiles":"C#Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)cc(NS(C)(=O)=O)c4OC)c4ccccc34)n2)cc(C(=O)NCCOCCOCCOC)c1","inchiKey":"FWXVGKSWZJEPQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOP-1288","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TOP-1288","TOP1288","Top-1288","Top1288"],"crossReferences":{"drugbank":["DB14839"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707309","canonicalSmiles":"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F","inchiKey":"IBMWAUVJJROIMB-IWEBAUSJSA-N","drugType":"Protein","blackBoxWarning":false,"name":"FEXAPOTIDE TRIFLUTATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL3545061","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fexapotide triflutate","NX-1207","NX-1207 TRIFLUOROACETATE"],"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3716365","canonicalSmiles":"O=c1nc(OC[C@@H]2COCCO2)cc2n1CCc1cc(C#CC3CC3)ccc1-2","inchiKey":"IRBAWVGZNJIROV-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLPG-1205","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glpg-1205","Glpg1205"],"crossReferences":{"drugbank":["DB15346"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL375112","canonicalSmiles":"C[C@@H](C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)c2cc3cc(Cl)ccc3[nH]2)C1=O","inchiKey":"BHNMMFGOJRIAEZ-LRDDRELGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL375112","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07848"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL383189","canonicalSmiles":"CC(C)NCCCn1c(Sc2cc3c(cc2Br)OCO3)nc2c(N)ncnc21","inchiKey":"MWGWLDJLENCVRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL383189","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07877"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833393","drugType":"Antibody","blackBoxWarning":true,"name":"EMICIZUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hemlibra"],"synonyms":["ACE-910","ACE910","Emicizumab"],"crossReferences":{"DailyMed":["emicizumab"]},"count":2,"approvedIndications":["MP_0001914","Orphanet_98878"],"linkedTargets":{"rows":["ENSG00000126218","ENSG00000101981"],"count":2},"linkedDiseases":{"rows":["MP_0001914","Orphanet_169802","Orphanet_98878"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for hemophilia a and hemorrhage. This drug has a black box warning from the FDA."}
{"id":"CHEMBL38681","canonicalSmiles":"Clc1ccc2c(c1Cl)CNCCC2","inchiKey":"IADAQXMUWITWNG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-134046","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-134046"],"crossReferences":{"drugbank":["DB04273"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3943182","canonicalSmiles":"[2H]C([2H])([2H])C([2H])(n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)C([2H])([2H])[2H]","inchiKey":"GYLDXIAOMVERTK-QXMYYZBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3943182","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3545097","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989678","canonicalSmiles":"C1CNCCN1.C1CNCCN1.C1CNCCN1.O.O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"LWMBPKJYEQGDLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERAZINE CITRATE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3990694","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antepar","Bryrel","Multifuge","Piperazine citrate","Vermidol"],"synonyms":["Piperazine citrate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954."}
{"id":"CHEMBL3989694","canonicalSmiles":"Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1.O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O","inchiKey":"ZIMCQJVMPKQQPB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OLANZAPINE PAMOATE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL715","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zyprexa relprevv"],"synonyms":["Olanzapine embonate","Olanzapine pamoate","Olanzapine pamoate monohydrate"],"crossReferences":{"DailyMed":["olanzapine%20pamoate"]},"count":1,"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000102468","ENSG00000151577","ENSG00000147246"],"count":5},"linkedDiseases":{"rows":["EFO_0000692"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2009 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989920","canonicalSmiles":"O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Na+]","inchiKey":"NBDQGOCGYHMDSJ-NRFPMOEYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PITAVASTATIN SODIUM","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201753","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nikita"],"synonyms":["Pitavastatin sodium"],"count":2,"approvedIndications":["HP_0003119","EFO_0003774"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["HP_0003119","EFO_0003774"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for abnormal circulating lipid concentration and hyperlipidemia."}
{"id":"CHEMBL3989969","canonicalSmiles":"C[C@@H](O)C(=N)NS(=O)(=O)c1cc(C(=O)C(C(=O)c2cc(F)ccc2F)=C2Nc3ccccc3N2)ccc1F","inchiKey":"CWNLBPBIFALUQD-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OPIGOLIX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-1707","ASP1707","Opigolix","Opigolixum"],"count":2,"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0001065"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3989984","drugType":"Antibody","blackBoxWarning":false,"name":"NAVICIXIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Navicixizumab","OMP-305B83","Omp 305b83"],"count":4,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3990034","drugType":"Gene","blackBoxWarning":false,"name":"FIDANACOGENE ELAPARVOVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fidanacogene elaparvovec","PF-06838435","SPK 101","SPK-1001","SPK-9001","SPK-FIX Padua","Spark 101"],"count":1,"description":"Gene drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4071161","canonicalSmiles":"CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1","inchiKey":"SEJLPXCPMNSRAM-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIRABRUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-4059","Gs-4059","ONO-4059","ONO-4059(FREE BASE)","Ono-4059","Tirabrutinib"],"crossReferences":{"drugbank":["DB15227"]},"count":4,"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000095","EFO_0000699","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL415606","canonicalSmiles":"CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(NC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O","inchiKey":"MEUCPCLKGZSHTA-XYAYPHGZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DEGARELIX","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Firmagon"],"synonyms":["Degarelix","FE200486 (AS ACETATE SALT)"],"crossReferences":{"DailyMed":["degarelix%20acetate"],"drugbank":["DB06699"]},"childChemblIds":["CHEMBL2028987"],"count":9,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000545","MONDO_0100096","EFO_0001065","EFO_0000673","MONDO_0007254","EFO_0000196","EFO_0000284","MONDO_0021259","EFO_0000228","MONDO_0008315","EFO_0001663","HP_0011277"],"count":13},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for neoplasm and has 8 investigational indications."}
{"id":"CHEMBL416526","canonicalSmiles":"CN(C)CCc1c[nH]c2ccc(O)cc12","inchiKey":"VTTONGPRPXSUTJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUFOTENINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bufotenine"],"crossReferences":{"PubChem":["124954092","144206443"],"Wikipedia":["Bufotenin"],"drugbank":["DB01445"],"chEBI":["3210"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL417656","canonicalSmiles":"CC1(C)O[C@H]2[C@@H]3OS(=O)(=O)O[C@@H]3CO[C@@]2(COS(N)(=O)=O)O1","inchiKey":"GGOAQSGCBDRTHT-JAKMQLQISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL417656","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02894"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4212531","canonicalSmiles":"CC(C)(CO)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cn3)c2)c2cnc(N)nc21","inchiKey":"BPIWZDNVMQQBQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06273340","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF06273340","Pf-06273340"],"crossReferences":{"drugbank":["DB12269"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297162","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"MUPARFOSTAT SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL4297163","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Muparfostat sodium","PI-88"],"description":"Oligosaccharide drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297258","canonicalSmiles":"C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OCC(F)(F)F)nc1N(C)CCN(C)C","inchiKey":"GHKOONMJXNWOIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALFLUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AST-2818","AST2818","Alflutinib"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297282","canonicalSmiles":"CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1sc(-c2ncco2)nc1-c1ccccc1)C1CCCCC1","inchiKey":"HSHPBORBOJIXSQ-HARLFGEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GDC-0917","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CUDC-427","Cudc 427","Cudc-427","Gdc-0917"],"crossReferences":{"drugbank":["DB12336"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297284","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@H](O)CC1=C[C@@H]3O","inchiKey":"JJKOQZHWYLMASZ-FJWDNACWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HE3286","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HE 3286","HE-3286","He3286"],"crossReferences":{"drugbank":["DB05212"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297318","canonicalSmiles":"COc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC(CC#CCN3CCOCC3)C(=O)O)cc2)cc1","inchiKey":"JAYVKNDQKXUNOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PG-530742","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PG-116800","PGE-7113313","PGE7113313","Pg-530742"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297361","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CC[C@@H](CC)C(C)C)C[C@@H](O)C[C@@H]1O","inchiKey":"NWFOBODUYTUMNC-VPSCEVSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1.ALPHA.-HYDROXYVITAMIN D5","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1.alpha.-hydroxyvitamin d5","CARD-024","Card-024","LS-144738","MN-201"],"crossReferences":{"drugbank":["DB13097"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297415","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTIMONY CATION (5+)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antimony cation (5+)","Pentavalent antimony"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297445","canonicalSmiles":"Cc1cc(Cc2c(C)nn(CCC(=O)O)c2C)c2c(c1O)CCC2","inchiKey":"OFUOCIUIWKDKPA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRC-150094","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TRC150094","Trc-150094","Trc150094"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297466","canonicalSmiles":"CC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H]1CSSC[C@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(N)=O)C(=O)O)NC(=O)[C@@H](CCC(N)=O)NC1=O","inchiKey":"MDQMFOHHSFMREL-YIYMUJAPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GO-203-2C","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GO-203-2C","Go-203-2c"],"crossReferences":{"drugbank":["DB15008"]},"count":3,"description":"Protein drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297538","canonicalSmiles":"CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](CN2CCc3ncc(C(F)(F)F)cc3C2)(C(C)C)C1","inchiKey":"UNVWTBOGMHPKJM-CWKRKGSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0812","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-0812","Mk0812"],"crossReferences":{"drugbank":["DB11990"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297558","drugType":"Antibody","blackBoxWarning":false,"name":"INOTUZUMAB","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Besponsa"],"synonyms":["G544","Inotuzumab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL4297647","canonicalSmiles":"CC(C)Oc1ccc(-c2nc(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6(C)CC6)C[C@H]5/C=C\\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)c3oc4ccccc4c3n2)cc1","inchiKey":"GZRNOYTVBWWFLJ-NTPALUMKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FURAPREVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Furaprevir","TG-2349","Tg-2349"],"crossReferences":{"drugbank":["DB12785"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297715","drugType":"Antibody","blackBoxWarning":false,"name":"CAMRELIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Camrelizumab","SHR-1210","Shr-1210"],"count":38,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 38 investigational indications."}
{"id":"CHEMBL4297874","drugType":"Unknown","blackBoxWarning":false,"name":"AFM-11","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AFM11","Afm-11","Afm11"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297885","drugType":"Protein","blackBoxWarning":false,"name":"SOLNATIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AP-301","AP301","Ap-301","Ap301","Solnatide"],"count":2,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297891","drugType":"Antibody","blackBoxWarning":false,"name":"CUSATUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Argx-110","Cusatuzumab"],"count":4,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4298188","drugType":"Antibody","blackBoxWarning":false,"name":"ODESIVIMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Odesivimab","REGN3471"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL438","canonicalSmiles":"Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1","inchiKey":"QPPBRPIAZZHUNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAMERAZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mesulfa","Methypyrimal","Sulfamethyldiazine","Sumedin"],"synonyms":["Sulfamerazine","Sulfamerazine (trisulfapyrimidines)"],"crossReferences":{"PubChem":["11112279","124882173","14742044","170464738","26748261","50086854"],"Wikipedia":["Sulfamerazine"],"drugbank":["DB01581"],"chEBI":["102130"]},"childChemblIds":["CHEMBL2107260"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for bacterial disease."}
{"id":"CHEMBL441","canonicalSmiles":"CCCC(C)C1(CC)C(=O)NC(=S)NC1=O","inchiKey":"IUJDSEJGGMCXSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOPENTAL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Thiopental","Thiopental ciii"],"crossReferences":{"PubChem":["29215503"],"drugbank":["DB00599"],"chEBI":["102166"]},"childChemblIds":["CHEMBL738"],"count":4,"linkedTargets":{"rows":["ENSG00000145864","ENSG00000166206","ENSG00000163288"],"count":3},"linkedDiseases":{"rows":["EFO_0008526","EFO_0006834","HP_0000486","EFO_0001645","EFO_1001454","MONDO_0043510"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 4 investigational indications."}
{"id":"CHEMBL452","canonicalSmiles":"O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1","inchiKey":"DGBIGWXXNGSACT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLONAZEPAM","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clonazepam","Klonopin","Klonopin rapidly disintegrating","Rivotril"],"synonyms":["Clonazepam","Clonazepam civ","NSC-179913","RO 5-4023","RO-5-4023","RO-54023"],"crossReferences":{"DailyMed":["clonazepam"],"Wikipedia":["Clonazepam"],"drugbank":["DB01068"],"chEBI":["3756"]},"count":13,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000113327","ENSG00000151834","ENSG00000163285","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0008526","EFO_0005762","EFO_0004262","EFO_1000924","HP_0000726","EFO_0001358","EFO_1001917","EFO_0003843","EFO_0007191","EFO_0000474","MONDO_0002050","EFO_1000632","EFO_1000850","EFO_0005230","EFO_0000692","EFO_0007262","EFO_0009492","EFO_0007462"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and is indicated for epilepsy and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4594271","canonicalSmiles":"N#Cc1cccc(C(NCC2CC2)c2ccc(F)c(NC(=O)c3cc(C(F)(F)F)nn3-c3cccc(CN)c3)c2)c1","inchiKey":"UXNXMBYCBRBRFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEROTRALSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BCX-7353","BCX7353","Bcx7353","Berotralstat"],"childChemblIds":["CHEMBL4594272"],"count":1,"linkedTargets":{"rows":["ENSG00000164344"],"count":1},"linkedDiseases":{"rows":["Orphanet_91378"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594402","canonicalSmiles":"CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(OCCOc5ccc6c7c5O[C@@H]5[C@]78CCN(CC7CC7)[C@H](C6)[C@]86CC[C@@]5(OC)[C@@H]([C@](C)(O)C(C)(C)C)C6)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5","inchiKey":"LEQOVFCHMOTJKU-WJVXOHEGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORP-101","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Orp-101"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594579","drugType":"Antibody","blackBoxWarning":false,"name":"FELZARTAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Felzartamab","MOR-03087","MOR-202","MOR03087","Mor03087","Mor202","TJ-202","TJ202"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594583","drugType":"Unknown","blackBoxWarning":false,"name":"RECOMBINANT METHIONYL HUMAN BRAIN-DERIVED NEUROTROPHIC FACTOR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OTO-413","OTO-413 (BDNF)","Oto-413","Recombinant methionyl human brain-derived neurotrophic factor"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL474024","canonicalSmiles":"O=C(N/N=C/c1cc(Br)c(O)c(Br)c1O)c1ccc(Cl)cc1","inchiKey":"ZDMUFSJTENTNDA-NGYBGAFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL474024","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06950"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489514","canonicalSmiles":"Cc1csc(NC(=O)c2cc(Sc3nncn3C)ccc2N)n1","inchiKey":"JEBOJMQHVUEKBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL489514","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07358"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL517199","canonicalSmiles":"Cc1cccc(C)c1NC(=O)c1cc(S(N)(=O)=O)c(Cl)cc1O","inchiKey":"MTZBBNMLMNBNJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XIPAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diurexan"],"synonyms":["BE-1293","MJF 10,938","Xipamide"],"crossReferences":{"PubChem":["144206528","170466623"],"Wikipedia":["Xipamide"],"drugbank":["DB13803"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL518800","canonicalSmiles":"CC[C@H](CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2ncn(C(C)C)c2n1","inchiKey":"HOCBJBNQIQQQGT-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL518800","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08463"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL529888","canonicalSmiles":"Cc1ccc(S(=O)(=O)NC(=O)N[C@H]2[C@H]3CC[C@@](C)([C@H]2O)C3(C)C)cc1","inchiKey":"RMTYNAPTNBJHQI-LLDVTBCESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLIBORNURIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glutril"],"synonyms":["Glibornuride","RO 6-4563"],"crossReferences":{"drugbank":["DB08962"]},"count":1,"approvedIndications":["EFO_0000400"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for diabetes mellitus."}
{"id":"CHEMBL536971","canonicalSmiles":"Cl.NCCCC(N)(C(=O)O)C(F)F","inchiKey":"VKDGNNYJFSHYKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-EFLORNITHINE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL830","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DL-alpha-Difluoromethylornithine HCl","Eflornithine HCl","Eflornithine Hydrocloride","L-eflornithine hydrochloride"],"crossReferences":{"PubChem":["11532866","144204775","170465007","50106206","56320809"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL549748","canonicalSmiles":"O=C(O)Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1","inchiKey":"PPJYSSNKSXAVDB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAC","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Levothyroxine sodium impurity, t4-acetic acid-","Tetrac"],"crossReferences":{"PubChem":["144213801"],"drugbank":["DB01751"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL561371","canonicalSmiles":"CCCCCCCC/C(=C\\CCCCCCCC(=O)O)[N+](=O)[O-]","inchiKey":"WRADPCFZZWXOTI-BMRADRMJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CXA-10","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CXA-10","Cxa-10"],"crossReferences":{"drugbank":["DB15026"],"chEBI":["86285"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL566757","canonicalSmiles":"O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1","inchiKey":"KPBNHDGDUADAGP-VAWYXSNFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPORINAD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APO 866","APO-866","APO866","Daporinad","FK 866","FK-866","K 22.175"],"crossReferences":{"drugbank":["DB12731"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL589","canonicalSmiles":"CCCN(CCC)CCc1cccc2c1CC(=O)N2","inchiKey":"UHSKFQJFRQCDBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ROPINIROLE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Requip"],"synonyms":["Requip","Ropinirole","SK&F 101468"],"crossReferences":{"DailyMed":["ropinirole%20hydrochloride"],"PubChem":["104171231","11111741","144203807","170465139","26750081","90341563"],"Wikipedia":["Ropinirole"],"drugbank":["DB00268"],"chEBI":["8888"]},"childChemblIds":["CHEMBL1200411"],"count":6,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["EFO_0002610","EFO_0004714","EFO_0000289","EFO_0005687","MONDO_0002009","EFO_0002508","EFO_0000712","EFO_0009846","EFO_0007319","EFO_0004270"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for parkinson's disease and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL607","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(C)CC1","inchiKey":"XADCESSVHJOZHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MEPERIDINE","yearOfFirstApproval":1942,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["IDS-NP-001","Meperidine","Pethidine"],"crossReferences":{"DailyMed":["meperidine%20hydrochloride"],"Wikipedia":["Pethidine"],"drugbank":["DB00454"],"chEBI":["6754"]},"childChemblIds":["CHEMBL429713","CHEMBL1701"],"count":3,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["HP_0002140","EFO_0003819","EFO_0003832","EFO_0004273","EFO_0003843","HP_0011868","EFO_0005251"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1942 and is indicated for pain and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL631","canonicalSmiles":"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1","inchiKey":"JWHAUXFOSRPERK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROPAFENONE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GNF-Pf-4594","Propafenone","Rythmol"],"crossReferences":{"DailyMed":["propafenone%20hydrochloride"],"PubChem":["104171212","124881115","144203779","170464755","26752315","26752316","50105251","50105252","90341088"],"Wikipedia":["Propafenone"],"drugbank":["DB01182"],"chEBI":["63619"]},"childChemblIds":["CHEMBL1201063"],"count":6,"approvedIndications":["EFO_0004269"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000043591","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169252","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":12},"linkedDiseases":{"rows":["EFO_0004269","EFO_0000275","EFO_0004287","EFO_0005306","EFO_0003144","EFO_0004278","EFO_0000612"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and is indicated for cardiac arrhythmia and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL672","canonicalSmiles":"CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1","inchiKey":"YMTINGFKWWXKFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOFIBRATE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antara","Antara (micronized)","Fenofibrate","Fenofibrate (micronized)","Fenogal","Fenoglide","Lipantil","Lipantil micro 200","Lipantil micro 267","Lipantil micro 67","Lipidil","Lipofen","Supralip 160","Tricor","Tricor (micronized)","Triglide"],"synonyms":["Fenofibrate","NSC-281319"],"crossReferences":{"DailyMed":["fenofibrate"],"PubChem":["104171156","11111181","11111182","124880099","144203698","144210471","170464718","174007303","26746914","26751450","50103926","56422492","85231046","855565","90340778"],"TG-GATEs":["79"],"Wikipedia":["Fenofibrate"],"drugbank":["DB01039"],"chEBI":["5001"]},"count":25,"approvedIndications":["HP_0003124","HP_0003119","EFO_0000319"],"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["EFO_1001249","EFO_0003774","MONDO_0037748","EFO_1001486","EFO_1000727","EFO_0003829","EFO_0004211","EFO_0003914","HP_0003119","HP_0003124","EFO_0001645","EFO_0000180","EFO_0003770","EFO_0009516","EFO_0000319","EFO_0001073","Orphanet_309005","EFO_0000537","EFO_0000195","EFO_0000589","Orphanet_399","EFO_0004268","MONDO_0100096","Orphanet_412","Orphanet_79211","EFO_0001378","EFO_0001360","HP_0012594"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 3 approved and 22 investigational indications."}
{"id":"CHEMBL7087","canonicalSmiles":"NCCc1ccc(S(N)(=O)=O)cc1","inchiKey":"FXNSVEQMUYPYJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-(2-Aminoethyl)Benzenesulfonamide","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-(2-Aminoethyl)Benzenesulfonamide"],"crossReferences":{"PubChem":["24841210"],"drugbank":["DB08782"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL75124","canonicalSmiles":"CCCCCCCCC(=O)NCc1ccc(O)c(OC)c1","inchiKey":"RGOVYLWUIBMPGK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NONIVAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AH-23491X","FEMA NO. 2787","NSC-172795","Nonivamide"],"crossReferences":{"PubChem":["11111961","144203853","144211535","170466476","26747691","26753670","50107151","56463512","85231285"],"drugbank":["DB11324"],"chEBI":["46936"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL797","canonicalSmiles":"CN1C(=O)CC(c2ccccc2)C1=O","inchiKey":"WLWFNJKHKGIJNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENSUXIMIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Milontin"],"synonyms":["Phensuximide"],"crossReferences":{"PubChem":["144203933","170465315","56463169"],"Wikipedia":["Phensuximide"],"drugbank":["DB00832"],"chEBI":["8079"]},"count":1,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000100346","ENSG00000006283","ENSG00000196557"],"count":3},"linkedDiseases":{"rows":["EFO_0000474"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for epilepsy."}
{"id":"CHEMBL82304","canonicalSmiles":"Cc1cc(CCCOc2c(C)cc(-c3nnn(C)n3)cc2C)on1","inchiKey":"RVZKQTQAFHEOKT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL82304","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08713"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL83063","canonicalSmiles":"CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1","inchiKey":"IOVGROKTTNBUGK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RITODRINE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["DU-21220","Ritodrine"],"crossReferences":{"PubChem":["174007152"]},"childChemblIds":["CHEMBL1367605"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0003917"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991."}
{"id":"CHEMBL8739","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\CCCCCCCC(=O)O","inchiKey":"DTOSIQBPPRVQHS-PDBXOOCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINOLENIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204622","144208925","144213639","17388945","26752892","29215108","50105513","57260459"],"Wikipedia":["Alpha-Linolenic_acid"],"drugbank":["DB00132"],"chEBI":["27432"]},"childChemblIds":["CHEMBL3122087"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL887","canonicalSmiles":"C#CCN[C@@H]1CCc2ccccc21","inchiKey":"RUOKEQAAGRXIBM-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RASAGILINE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AGN-1135","Azilect","Rasagiline","TV-1030"],"crossReferences":{"DailyMed":["rasagiline%20mesylate"],"Wikipedia":["Rasagiline"],"drugbank":["DB01367"],"chEBI":["63620"]},"childChemblIds":["CHEMBL1201142"],"count":5,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000069535"],"count":1},"linkedDiseases":{"rows":["EFO_1001050","Orphanet_683","EFO_0002508","EFO_0000249","EFO_0000253","EFO_0005773","EFO_0004270","EFO_0000692"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for parkinson's disease and has 4 investigational indications."}
{"id":"CHEMBL935","canonicalSmiles":"N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1.O=S(=O)(O)CCO","inchiKey":"NYRHYBFMOOPIRI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAMIDINE ISETHIONATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL55","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112938","11533059","124882733","17388789","26747405","26747406","26753136","489585","56422094"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL962","canonicalSmiles":"CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2O/C(=C\\CCCC(=O)[O-])C[C@@H]21.[Na+]","inchiKey":"LMHIPJMTZHDKEW-XQYLJSSYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"EPOPROSTENOL SODIUM","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1139","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Epoprostenol sodium","Flolan","Veletri"],"synonyms":["Epoprostenol sodium","Epoprostenolsodium","Prostacyclin sodium salt","U-53,217A","U-53217A"],"crossReferences":{"DailyMed":["epoprostenol%20sodium"],"PubChem":["144205984"],"Wikipedia":["Prostacyclin"]},"linkedTargets":{"rows":["ENSG00000160013"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995."}
